News & Announcements

President’s Letter from Dr. C. Buddy Creech – “Putting Our Money Where Our Mouths Are” and Other Idioms

I’ve always had a soft spot for idioms and maxims. My dad’s go-to phrase was “well, if a frog had wings, it wouldn’t bump its butt every time it hopped.” I’m not sure that it had the desired effect of eradicating my childhood excuse making, but it certainly made me smile. My longtime mentor, Dr….

May. 4, 2022

In The News: Measles Cases Jump 79% in 2022 After COVID Hit Vaccination Campaigns

In a story by Reuters, data from UNICEF and WHO show cases of measles jumped 79% in the first two months of 2022 compared to 2021. Reported cases for January and February of this year totaled 17,338 worldwide, up from 9,665 for the same period of last year. The leap has been attributed to disruptions…

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved for adults and adolescents who weigh at least 88 pounds. Last week’s decision expands the pool of patients eligible for the injection to children as…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare Epidemiology of America (SHEA), Pediatric Infectious Diseases Society (PIDS) and Society of Infectious Diseases Pharmacists (SIDP), we strongly urge you to pass an emergency supplemental…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an investigator at ACCORDS (Adult and Child Center for Health Outcomes Research and Delivery Science), and the Director of the Colorado Children’s Outcomes Network (COCONet), Colorado’s…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a decade ago, the Global Vaccine Data Network (GVDN) struggled to secure stable funding until a proposal was accepted by the CDC last year following the…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial infections amenable to antibiotic treatment. The findings show that, even when throat swabs reveal bacteria in children with respiratory infections, antibiotics make little difference in…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of pediatric ID, she was inspired to apply for a PIDS Fellowship award. The support from PIDS enabled Dr. Shane to pursue her research ambition and…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we thought was possible, developing endurance, resourcefulness, and character in the process. As a society, PIDS is committed to building the infrastructure necessary to become the…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from the Week 16 interim analysis of an ongoing MOCHA trial being run by one of the pharmaceutical companies involved in development and the International Maternal…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children remain less susceptible to hospitalization or death than adults, at least 400 children ages 4 and younger have died from COVID, according to the CDC….

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of congenital Zika virus infection that she developed, in part, due to research during her fellowship and instructor year supported through the PIDS Foundation’s Dr. Stanley…

Improving the health of children worldwide through philanthropic support of scientific and educational programs.

This site uses cookies to provide a better experience for you